Literature DB >> 16270208

[Diagnostics for diseases of the gallbladder and biliary tract from the viewpoint of the internist and surgeon. Demands made on radiological diagnostics].

F M Reimann1, H Friess.   

Abstract

Jaundice and colic pain of the right upper quadrant are the main symptoms of biliary diseases. Gallstone-related diseases often lead to hospital admission. The evaluation of a patient with biliary symptoms requires a combination of history taking, physical examination, laboratory analysis, and imaging modalities. A high-quality magnetic resonance imaging (MRI) or computed tomography (CT) scan is usually sufficient to evaluate a patient with painless jaundice. Ultrasonography is helpful as an initial screening test to guide the diagnostic work-up. Invasive methods (e.g., ERCP) are mainly used for palliation of patients with incurable disease.

Entities:  

Mesh:

Year:  2005        PMID: 16270208     DOI: 10.1007/s00117-005-1286-y

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  31 in total

1.  A prospective study of common bile duct calculi in patients undergoing laparoscopic cholecystectomy: natural history of choledocholithiasis revisited.

Authors:  Chris Collins; Donal Maguire; Adrian Ireland; Edward Fitzgerald; Gerald C O'Sullivan
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

2.  The role of endoscopic retrograde cholangiopancreatography in patients with laparoscopic cholecystectomies.

Authors:  R A Erickson; B Carlson
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

3.  Prospective evaluation of the sonographic Murphy sign in suspected acute cholecystitis.

Authors:  P W Ralls; J Halls; S A Lapin; M F Quinn; U L Morris; W Boswell
Journal:  J Clin Ultrasound       Date:  1982-03       Impact factor: 0.910

4.  Can endoscopic ultrasound or magnetic resonance cholangiopancreatography replace ERCP in patients with suspected biliary disease? A prospective trial and cost analysis.

Authors:  J M Scheiman; R C Carlos; J L Barnett; G H Elta; T T Nostrant; W D Chey; I R Francis; P S Nandi
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

5.  Association of clinical and laboratory variables with ultrasound findings in right upper quadrant abdominal pain.

Authors:  Lisa D Mills; Trevor Mills; Barbara Foster
Journal:  South Med J       Date:  2005-02       Impact factor: 0.954

6.  Incidence and management of Mirizzi syndrome during laparoscopic cholecystectomy.

Authors:  M Schäfer; R Schneiter; L Krähenbühl
Journal:  Surg Endosc       Date:  2003-05-13       Impact factor: 4.584

7.  Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.

Authors:  Angelo Andriulli; Luigi Solmi; Silvano Loperfido; Pietro Leo; Virginia Festa; Angelo Belmonte; Fulvio Spirito; Michele Silla; Giovambattista Forte; Vittorio Terruzzi; Giorgio Marenco; Enrico Ciliberto; Antonio Sabatino; Fabio Monica; Maria Rita Magnolia; Francesco Perri
Journal:  Clin Gastroenterol Hepatol       Date:  2004-08       Impact factor: 11.382

8.  Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography.

Authors:  Antonio Soriano; Antoni Castells; Carmen Ayuso; Juan Ramón Ayuso; Maria Teresa de Caralt; Maria Angels Ginès; Maria Isabel Real; Rosa Gilabert; Llorenç Quintó; Antoni Trilla; Faust Feu; Xavier Montanyà; Laureano Fernández-Cruz; Salvador Navarro
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

Review 9.  Useful markers for predicting severity and monitoring progression of acute pancreatitis.

Authors:  Jens Werner; Werner Hartwig; Waldemar Uhl; Christophe Müller; Markus W Büchler
Journal:  Pancreatology       Date:  2003       Impact factor: 3.996

10.  Postcholecystectomy symptoms. A prospective study of gall stone patients before and two years after surgery.

Authors:  E Ros; D Zambon
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.